Maria Nordengrün

Maria Nordengrün

Auto-generated profile, based on publicly available information

Maria Nordengrün

Department of Immunology, University Medicine Greifswald, Greifswald, Germany

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
SSSebastian Stentzel
Sebastian Stentzel
ATAndrea R. Teufelberger
Andrea R. Teufelberger
MNMaria Nordengrün
Maria Nordengrün
JKJulia Kolata
Julia Kolata
FSFrank Schmidt
Frank Schmidt
BBBarbara Bröker
Barbara Bröker
A substantial subgroup of asthmatic patients have "nonallergic" or idiopathic asthma, which often takes a severe course and is difficult to treat. The cause might be allergic reactions to the gram-positive pathogen Staphylococcus aureus, a frequent colonizer of the upper airways. However, the driving allergens of S aureus have remained elusive. We sought to search for potentially allergenic S aureus proteins and characterize the immune response directed against them. S aureus extracellular proteins targeted by human serum IgG4 were identified by means of immunoblotting to screen for potential bacterial allergens. Candidate antigens were expressed as recombinant proteins and used to analyze the established cellular and humoral immune responses in healthy adults and asthmatic patients. The ability to induce a type 2 immune response in vivo was tested in a mouse asthma model. We identified staphylococcal serine protease-like proteins (Spls) as dominant IgG4-binding S aureus proteins. SplA through SplF are extracellular proteases of unknown function expressed by S aureus in vivo. Spls elicited IgE antibody responses in most asthmatic patients. In healthy S aureus carriers and noncarriers, peripheral blood T cells elaborated TH2 cytokines after stimulation with Spls, as is typical for allergens. In contrast, TH1/TH17 cytokines, which dominated the response to S aureus α-hemolysin, were of low concentration or absent. In mice inhalation of SplD without adjuvant induced lung inflammation characterized by TH2 cytokines and eosinophil infiltration. We identify Spls as triggering allergens released by S aureus, opening prospects for diagnosis and causal therapy of asthma.

1 February 2018 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
ATAndrea R. Teufelberger
Andrea R. Teufelberger
MNMaria Nordengrün
Maria Nordengrün
HBHarald Braun
Harald Braun
TMTania Maes
Tania Maes
KGKatrien De Grove
Katrien De Grove
Olga KryskoOlga Krysko
Olga Krysko

1 October 2015 in Journal of Proteomics
Verified
Journal Article
Open access
SSSebastian Stentzel
Sebastian Stentzel
NSNandakumar Sundaramoorthy
Nandakumar Sundaramoorthy
SMStephan Michalik
Stephan Michalik
MNMaria Nordengrün
Maria Nordengrün
SSSarah Schulz
Sarah Schulz
BBBarbara Bröker
Barbara Bröker
Although Staphylococcus aureus is a prominent cause of infections, no vaccine is currently available. Active vaccination relies on immune memory, a core competence of the adaptive immune system. To elucidate whether adaptive immunity can provide protection from serious complications of S. aureus infection, a prospective observational study of 44 patients with S. aureus infection complicated by bacteremia was conducted. At diagnosis, serum IgG binding to S. aureus extracellular proteins was quantified on immunoblots and with Luminex-based FLEXMAP 3D™ assays comprising 64 recombinant S. aureus proteins. Results were correlated with the course of the infection with sepsis as the main outcome variable. S. aureus-specific serum IgG levels at diagnosis of S. aureus infection were lower in patients developing sepsis than in patients without sepsis (P<0.05). The pattern of IgG binding to eight selected S. aureus proteins correctly predicted the disease course in 75% of patients. Robust immune memory of S. aureus was associated with protection from serious complications of bacterial invasion. Serum IgG binding to eight conserved S. aureus proteins enabled stratification of patients with high and low risk of sepsis early in the course of S. aureus infections complicated by bacteremia. S. aureus is a dangerous pathogen of ever increasing importance both in hospitals and in the community. Due to the crisis of antibiotic resistance, an urgent need exists for new strategies to combat S. aureus infections, such as vaccination. To date, however, all vaccine trials have failed in clinical studies. It is therefore unclear whether the adaptive immune system is at all able to control S. aureus in humans. The paper demonstrates the use of proteomics for providing an answer to this crucial question. It describes novel results of a prospective study in patients with S. aureus infection complicated by bloodstream invasion. Immune proteomic analysis shows that robust immune memory of S. aureus - reflected by strong serum IgG antibody binding to S. aureus antigens - is associated with clinical protection from sepsis. This lends support to the notion of a vaccine to protect against the most serious complications of S. aureus infection. Hence, the data encourage further efforts in vaccine development.

1 August 2018 in International Journal of Medical Microbiology
Verified
Journal Article
Open access
MNMaria Nordengrün
Maria Nordengrün
SMStephan Michalik
Stephan Michalik
UVUwe Volker
Uwe Volker
BBBarbara Bröker
Barbara Bröker
LGLidia Gómez-Gascón
Lidia Gómez-Gascón
Allergies are complex diseases featuring local tissue inflammation, which is characterized by an exaggerated type 2 immune response to environmental compounds known as allergens. Pollens, environmental fungi, and house dust mites are examples of common allergens. Bacteria have a dual role in allergy. Usually, they are associated with protection, however, certain bacterial species promote the development and exacerbation of allergic inflammation. Notably, IgE antibodies specific for bacterial antigens are found in the sera of allergic individuals. This implies that some bacterial factors are allergens, eliciting a specific type 2 immune response. However, to date, only a few of these are molecularly defined. This review summarizes the current knowledge about known bacterial allergens, and it provides an overview of the available techniques for the discovery of new allergens as well as for measuring the immune responses directed against them.

15 August 2018 in Microorganisms
Verified
Journal Article
Open access
PDF file
VDVS Narayana Murty Darisipudi
VS Narayana Murty Darisipudi
MNMaria Nordengrün
Maria Nordengrün
BBBarbara Bröker
Barbara Bröker
VPVincent Peton
Vincent Peton
Staphylococcus aureus (S. aureus) is a dangerous pathogen as well as a frequent colonizer, threatening human health worldwide. Protection against S. aureus infection is challenging, as the bacteria have sophisticated strategies to escape the host immune response. To maintain equilibrium with S. aureus, both innate and adaptive immune effector mechanisms are required. Dendritic cells (DCs) are critical players at the interface between the two arms of the immune system, indispensable for inducing specific T cell responses. In this review, we highlight the importance of DCs in mounting innate as well as adaptive immune responses against S. aureus with emphasis on their role in S. aureus-induced respiratory diseases. We also review what is known about mechanisms that S. aureus has adopted to evade DCs or manipulate these cells to its advantage.

25 September 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ATAndrea R. Teufelberger
Andrea R. Teufelberger
SNSharon Van Nevel
Sharon Van Nevel
PHPaco Hulpiau
Paco Hulpiau
MNMaria Nordengrün
Maria Nordengrün
SSSavvas N. Savvides
Savvas N. Savvides
Olga KryskoOlga Krysko
Olga Krysko
Staphylococcus aureus (S. aureus) can secrete a broad range of virulence factors, among which staphylococcal serine protease-like proteins (Spls) have been identified as bacterial allergens. The S. aureus allergen serine protease-like protein D (SplD) induces allergic asthma in C57BL/6J mice through the IL-33/ST2 signaling axis. Analysis of C57BL/6J, C57BL/6N, CBA, DBA/2, and BALB/c mice treated with intratracheal applications of SplD allowed us to identify a frameshift mutation in the serine (or cysteine) peptidase inhibitor, clade A, and member 3I (Serpina3i) causing a truncated form of SERPINA3I in BALB/c, CBA, and DBA/2 mice. IL-33 is a key mediator of SplD-induced immunity and can be processed by proteases leading to its activation or degradation. Full-length SERPINA3I inhibits IL-33 degradation in vivo in the lungs of SplD-treated BALB/c mice and in vitro by direct inhibition of mMCP-4. Collectively, our results establish SERPINA3I as a regulator of IL-33 in the lungs following exposure to the bacterial allergen SplD, and that the asthma phenotypes of mouse strains may be strongly influenced by the observed frameshift mutation in Serpina3i. The analysis of this protease-serpin interaction network might help to identify predictive biomarkers for type-2 biased airway disease in individuals colonized by S. aureus.